ASX
Neuren Pharmaceuticals Limited
NEU:ASX•Healthcare
Sensitive ASX Announcement
Neuren initiates manufacture of NNZ-2591 for Phase 2 trials
Published: 22/09/20, 09:45am (AEST)•2 pages